A randomized controlled trial of panretinal photocoagulation with and without intravitreal ranibizumab in treatment-naive eyes with non-high-risk proliferative diabetic retinopathy

Retina

Volumn 35, Issue 2, 2015, Pages 280-287

  Ferraz, Daniel A ^a,b   Vasquez, Lisa M ^a   Preti, Rony C ^a   Motta, Augusto ^a   Sophie, Raafay ^c   Bittencourt, Millena G ^c   Sepah, Yasir J ^b   Monteiro, Mário L R ^a   Nguyen, Quan Dong ^b   Takahashi, Walter Yukihiko ^a  

^a Medical Sciences School of Saint House of São Paulo   (Brazil)

^b 985540 Nebraska Medical Center   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

panretinal photocoagulation; proliferative diabetic retinopathy; ranibizumab

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC PATIENT; DIABETIC RETINOPATHY; DRUG EFFICACY; EYE EXAMINATION; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTERVENTION STUDY; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PANRETINAL PHOTOCOAGULATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA LUTEA; RETINAL THICKNESS; SURGICAL PATIENT; VISUAL ACUITY; VITREOUS HEMORRHAGE; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; RETINAL NEOVASCULARIZATION; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERVENTION STUDIES; INTRAVITREAL INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL NEOVASCULARIZATION; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84922399622     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000363     Document Type: Article

References (24)

1. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7 Ophthalmology 1991;98:S741-S756.
2. Early photocoagulation for diabetic retinopathy. ETDRS report number 9 Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98:S766-S785.
3. Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13 Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98:S834-S840.
4. Fong DS, Ferris FL III, Davis MD, Chew EY. Causes of severe visual loss in the Early Treatment Diabetic Retinopathy Study: ETDRS report no. 24 Early Treatment Diabetic Retinopathy Study Research Group. Am J Ophthalmol 1999;127:137-141.
5. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8 Ophthalmology 1981;88:583-600.
6. Ferris FL III. Photocoagulation for diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. JAMA 1991;266:1263-1265.
7. Vander JF, Duker JS, Benson WE, et al. Long-term stability and visual outcome after favorable initial response of proliferative diabetic retinopathy to panretinal photocoagulation. Ophthalmology 1991;98:1575-1579.
8. Flynn HW Jr, Chew EY, Simons BD, et al. Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17 The Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1992;99: 1351-1357.
9. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial- Diabetic Retinopathy Vitrectomy Study report 3 The Diabetic Retinopathy Vitrectomy Study Research Group. Ophthalmology 1988;95:1307-1320.
10. Tsujikawa A, Kiryu J, Dong J, et al. Quantitative analysis of diabetic macular edema after scatter laser photocoagulation with the scanning retinal thickness analyzer. Retina 1999;19:59-64.
11. Cho WB, Oh SB, Moon JW, Kim HC. Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy. Retina 2009;29:516-522.
12. Cho WB, Moon JW, Kim HC. Intravitreal triamcinolone and bevacizumab as adjunctive treatments to panretinal photocoagulation in diabetic retinopathy. Br J Ophthalmol 2010;94:858-863.
13. Thomas BJ, Shienbaum G, Boyer DS, Flynn HW Jr. Evolving strategies in the management of diabetic macular edema: clinical trials and current management. Can J Ophthalmol 2013;48:22-30.
14. Filho JA, Messias A, Almeida FP, et al. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy. Acta Ophthalmol 2011;89:e567-e572.
15. Googe JBA, Bressler NM, Qin H, et al. Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/ grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation. Retina 2011;31: 1009-1027.
16. Aiello LP, Brucker AJ, Chang S, et al. Evolving guidelines for intravitreous injections. Retina 2004;24:S3-S19.
17. Shimura M, Yasuda K, Nakazawa T, et al. Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision. Ophthalmology 2003;110:2386-2394.
18. McDonald HR, Schatz H. Macular edema following panretinal photocoagulation. Retina 1985;5:5-10.
19. Higgins KE, Meyers SM, Jaffe MJ, et al. Temporary loss of foveal contrast sensitivity associated with panretinal photocoagulation. Arch Ophthalmol 1986;104:997-1003.
20. Nguyen QD, Shah SM, Heier JS, et al. Primary end point (six months) results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) study. Ophthalmology 2009;116: 2175-2181.e1.
21. Nguyen QD, Shah SM, Khwaja AA, et al. Two-year outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) study. Ophthalmology 2010;117: 2146-2151.
22. Do DV, Nguyen QD, Khwaja AA, et al. Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment. JAMA Ophthalmol 2013;131:139-145.
23. Channa R, Sophie R, Khwaja AA, et al. Factors affecting visual outcomes in patients with diabetic macular edema treated with ranibizumab. READ-2 Study Group. Eye (Lond) 2014;28:269-278.
24. Preti RC, Vasquez Ramirez LM, Ribeiro Monteiro ML, et al. Structural and functional assessment of macula in patients with high-risk proliferative diabetic retinopathy submitted to panretinal photocoagulation and associated intravitreal bevacizumab injections: a comparative, randomised, controlled trial. Ophthalmologica 2013;230:1-8.